 |
|
Rhinocerebral MucormycosisTherapy With Amphotericin B Lipid Complex
Mark D. Strasser, MD;
Rebecca J. Kennedy, MD;
Rodney D. Adam, MD
Arch Intern Med. 1996;156(3):337-339.
Abstract
Rhinocerebral mucormycosis with intracranial involvement has a high mortality. The standard therapy consists of aggressive surgical débridement accompanied by high doses of amphotericin B deoxycholate. Even with this therapy, the mortality rate has been 48% in the series reported since 1980. We treated a 60-year-old diabetic woman with rhinocerebral mucormycosis involving the cavernous sinus whose infection responded to medical therapy with amphotericin B lipid complex. To our knowledge, this is the only well-documented medical cure of a patient with rhinocerebral mucormycosis and intracranial involvement.
(Arch Intern Med. 1996;156:337-339)
Author Affiliations
From the Departments of Surgery (Dr Kennedy), Medicine (Dr Adam), and Microbiology/Immunology (Dr Adam), University of Arizona College of Medicine, Tucson. Dr Strasser was a medical student at University of Arizona College of Medicine and is now a surgery resident (otorhinolaryngologist) at the University of Cincinnati (Ohio) College of Medicine.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Rhinocerebral Mucormycosis Acquired After a Short Course of Prednisone Therapy
Ferguson
JAOA: Journal of the American Osteopathic Association 2007;107:491-493.
ABSTRACT
| FULL TEXT
Current Perspectives on Ophthalmic Mycoses
Thomas
Clin. Microbiol. Rev. 2003;16:730-797.
ABSTRACT
| FULL TEXT
Fungal Sinusitis
deShazo et al.
NEJM 1997;337:254-259.
FULL TEXT
Rhinocerebral Mucormycosis: Cure Without Surgery?
Anand et al.
Arch Intern Med 1996;156:2262-2269.
ABSTRACT
|
